Terms: = Prostate cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338
22 results:
1. Complementary analysis of proteome-wide proteomics reveals changes in RNA binding protein-profiles during prostate cancer progression.
Aikio E; Koivukoski S; Kallio E; Sadeesh N; Niskanen EA; Latonen L
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1886. PubMed ID: 37591798
[TBL] [Abstract] [Full Text] [Related]
2. Financial Toxicities Persist for cancer Survivors Irrespective of Current cancer Status: An Analysis of Medical Expenditure Panel Survey.
Karim MA; Talluri R; Shastri SS; Kum HC; Shete S
Cancer Res Commun; 2022 Oct; 2(10):1119-1128. PubMed ID: 36531523
[TBL] [Abstract] [Full Text] [Related]
3. Reconstruction of clone- and haplotype-specific cancer genome karyotypes from bulk tumor samples.
Aganezov S; Raphael BJ
Genome Res; 2020 Sep; 30(9):1274-1290. PubMed ID: 32887685
[TBL] [Abstract] [Full Text] [Related]
4. Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
Conteduca V; Wetterskog D; Sharabiani MTA; Grande E; Fernandez-Perez MP; Jayaram A; Salvi S; Castellano D; Romanel A; Lolli C; Casadio V; Gurioli G; Amadori D; Font A; Vazquez-Estevez S; González Del Alba A; Mellado B; Fernandez-Calvo O; Méndez-Vidal MJ; Climent MA; Duran I; Gallardo E; Rodriguez A; Santander C; Sáez MI; Puente J; Gasi Tandefelt D; Wingate A; Dearnaley D; ; ; Demichelis F; De Giorgi U; Gonzalez-Billalabeitia E; Attard G
Ann Oncol; 2017 Jul; 28(7):1508-1516. PubMed ID: 28472366
[TBL] [Abstract] [Full Text] [Related]
5. Parkinson's disease and risk of prostate cancer: A Danish population-based case-control study, 1995-2010.
Jespersen CG; Nørgaard M; Borre M
Cancer Epidemiol; 2016 Dec; 45():157-161. PubMed ID: 27838564
[TBL] [Abstract] [Full Text] [Related]
6. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical prostatectomy in the Management of Unilateral prostate cancer: A Matched-Pair Analysis.
Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
[TBL] [Abstract] [Full Text] [Related]
7. S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells.
Amaral CL; Freitas LB; Tamura RE; Tavares MR; Pavan IC; Bajgelman MC; Simabuco FM
BMC Cancer; 2016 Aug; 16():602. PubMed ID: 27491285
[TBL] [Abstract] [Full Text] [Related]
8. Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with prostate cancer Treated with Radical prostatectomy.
Boehm K; Larcher A; Tian Z; Mandel P; Schiffmann J; Karakiewicz PI; Graefen M; Huland H; Tilki D
J Urol; 2016 Jul; 196(1):82-8. PubMed ID: 26925872
[TBL] [Abstract] [Full Text] [Related]
9. Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score.
Hu XH; Cammann H; Meyer HA; Jung K; Lu HB; Leva N; Magheli A; Stephan C; Busch J
Asian J Androl; 2014; 16(6):897-901. PubMed ID: 25130472
[TBL] [Abstract] [Full Text] [Related]
10. ddx6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract] [Full Text] [Related]
11. Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.
Noguchi M; Moriya F; Suekane S; Matsuoka K; Arai G; Matsueda S; Sasada T; Yamada A; Itoh K
Prostate; 2012 Jun; 72(8):834-45. PubMed ID: 21932426
[TBL] [Abstract] [Full Text] [Related]
12. [The epidemiological analysis of monitoring of the immune status in liquidators of consequences of the Chernobyl accident for early identification of risk groups and diagnostics of oncological diseases. Report 1].
Oradovskaia IV; Pashchenkova IuG; Feoktistov VV; Nikonova MF; Vikulov GKh; Bozheskaia NV; Smirnova NN
Radiats Biol Radioecol; 2011; 51(1):101-16. PubMed ID: 21520622
[TBL] [Abstract] [Full Text] [Related]
13. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
Pettaway CA; Lamerato LE; Eaddy MT; Edwards JK; Hogue SL; Crane MM
BJU Int; 2011 Oct; 108(8):1302-8. PubMed ID: 21371244
[TBL] [Abstract] [Full Text] [Related]
14. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract] [Full Text] [Related]
15. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
[TBL] [Abstract] [Full Text] [Related]
16. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract] [Full Text] [Related]
17. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men.
Veierød MB; Laake P; Thelle DS
Int J Cancer; 1997 Nov; 73(5):634-8. PubMed ID: 9398038
[TBL] [Abstract] [Full Text] [Related]
18. Neoplasms of unknown primary site: a clinicopathological study of autopsied patients.
Mayordomo JI; Guerra JM; Guijarro C; García-Prats MD; Gómez A; López-Brea M; González R; Hergueta P; López-Pino MA; Martínez-Tello F
Tumori; 1993 Oct; 79(5):321-4. PubMed ID: 8116074
[TBL] [Abstract] [Full Text] [Related]
19. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
[TBL] [Abstract] [Full Text] [Related]
20. Keratin patterns in prostatic hyperplasia and adenocarcinoma.
Svanholm H; Nielsen B; Starklint H
APMIS Suppl; 1988; 4():100-8. PubMed ID: 2465010
[TBL] [Abstract] [Full Text] [Related]
[Next]
